1. Home
  2. ALDX vs ALDF Comparison

ALDX vs ALDF Comparison

Compare ALDX & ALDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • ALDF
  • Stock Information
  • Founded
  • ALDX 2004
  • ALDF 2024
  • Country
  • ALDX United States
  • ALDF United States
  • Employees
  • ALDX N/A
  • ALDF N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • ALDF
  • Sector
  • ALDX Health Care
  • ALDF
  • Exchange
  • ALDX Nasdaq
  • ALDF NYSE
  • Market Cap
  • ALDX 160.8M
  • ALDF 313.9M
  • IPO Year
  • ALDX 2014
  • ALDF 2024
  • Fundamental
  • Price
  • ALDX $3.79
  • ALDF $10.51
  • Analyst Decision
  • ALDX Strong Buy
  • ALDF
  • Analyst Count
  • ALDX 2
  • ALDF 0
  • Target Price
  • ALDX $9.50
  • ALDF N/A
  • AVG Volume (30 Days)
  • ALDX 959.9K
  • ALDF 63.5K
  • Earning Date
  • ALDX 07-31-2025
  • ALDF 01-01-0001
  • Dividend Yield
  • ALDX N/A
  • ALDF N/A
  • EPS Growth
  • ALDX N/A
  • ALDF N/A
  • EPS
  • ALDX N/A
  • ALDF N/A
  • Revenue
  • ALDX N/A
  • ALDF N/A
  • Revenue This Year
  • ALDX N/A
  • ALDF N/A
  • Revenue Next Year
  • ALDX N/A
  • ALDF N/A
  • P/E Ratio
  • ALDX N/A
  • ALDF $100.51
  • Revenue Growth
  • ALDX N/A
  • ALDF N/A
  • 52 Week Low
  • ALDX $1.14
  • ALDF $9.90
  • 52 Week High
  • ALDX $7.20
  • ALDF $10.69
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 76.85
  • ALDF N/A
  • Support Level
  • ALDX $2.95
  • ALDF N/A
  • Resistance Level
  • ALDX $3.29
  • ALDF N/A
  • Average True Range (ATR)
  • ALDX 0.27
  • ALDF 0.00
  • MACD
  • ALDX 0.11
  • ALDF 0.00
  • Stochastic Oscillator
  • ALDX 95.89
  • ALDF 0.00

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About ALDF ALDEL FINL II INC

Aldel Financial II Inc is a Shell Company with various businesses.

Share on Social Networks: